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Introduction
Calcium (Ca2+) release from the sarcoplasmic reticulum (SR)
is the key event linking membrane depolarisation and
mechanical activity during excitation-contraction coupling
(EC-coupling) in the heart. Depolarisation of the sarcolemma
leads to activation of L-type voltage-operated Ca2+ channels
(VOCs). The consequent influx of Ca2+ provokes more
substantial Ca2+ release from closely apposed ryanodine
receptor (RyR) clusters on the SR by a process known as
Ca2+-induced Ca2+ release (CICR) (Callewaert, 1992;
Roderick et al., 2003). The essential elementary events
underlying EC-coupling are ‘Ca2+ sparks’, which result from
activation of a cluster of RyRs (Cheng et al., 1993; Rios,
2005). The spatial overlap and temporal summation of
signals from multiple Ca2+-spark sites leads to the rapid
homogenous Ca2+ transients that trigger coordinated
ventricular myocyte contraction (Bootman et al., 2001;
Guatimosim et al., 2002).
The force of contraction of the heart is regulated by the
interplay of multiple neurohormonal factors. Endothelin-1 (ET-
1) is one such agonist, and has a significant positive inotropic
effect in myocytes from different mammalian species. It has
also been demonstrated that ET-1 can cause arrhythmias
(Russell and Molenaar, 2000). The processes underlying the
inotropic and pro-arrhythmic effects of ET-1 are not entirely
clear. Proposed mechanisms include stimulation of Ca2+
release (Li et al., 2005; Mackenzie et al., 2002), enhanced
L-type Ca2+ current following activation of protein kinase C
(He et al., 2000) and sensitization of myofilaments following
either PKC-mediated phosphorylation (Pi et al., 2003) or
alkalinisation resulting from increased Na+-H+ exchange
(Russell and Molenaar, 2000).
Although ET-1 can provide short-term inotropic support for
failing hearts, this effect comes with the potential burden of
arrhythmogenesis and remodelling (Zolk et al., 2004). ET-1
concentration is increased in cardiac tissues during
pathological conditions such as congestive heart failure and
myocardial infarction (Duru et al., 2001; Russell and Molenaar,
2000). Understanding the mechanism of action of ET-1 is
therefore clinically important.
ET-1 is secreted by endocardial endothelial cells, as well as
being released by cardiac myocytes themselves. Both ET-1
Although ventricular cardiomyocytes express inositol 1,4,5-
trisphosphate [Ins(1,4,5)P3] receptors, it is unclear how
these Ca2+ channels contribute to the effects of Gq-coupled
agonists. Endothelin-1 augmented the amplitude of pacing-
evoked Ca2+ signals (positive inotropy), and caused an
increasing frequency of spontaneous diastolic Ca2+-release
transients. Both effects of endothelin-1 were blocked by an
antagonist of phospholipase C, suggesting that Ins(1,4,5)P3
and/or diacylglycerol production was necessary. The
endothelin-1-mediated spontaneous Ca2+ transients were
abolished by application of 2-aminoethoxydiphenyl borate
(2-APB), an antagonist of Ins(1,4,5)P3 receptors.
Incubation of electrically-paced ventricular myocytes with
a membrane-permeant Ins(1,4,5)P3 ester provoked the
occurrence of spontaneous diastolic Ca2+ transients with
the same characteristics and sensitivity to 2-APB as the
events stimulated by endothelin-1. In addition to evoking
spontaneous Ca2+ transients, stimulation of ventricular
myocytes with the Ins(1,4,5)P3 ester caused a positive
inotropic effect. The effects of endothelin-1 were compared
with two other stimuli, isoproterenol and digoxin, which
are known to induce inotropy and spontaneous Ca2+
transients by overloading intracellular Ca2+ stores. The
events evoked by isoproterenol and digoxin were dissimilar
from those triggered by endothelin-1 in several ways.
We propose that Ins(1,4,5)P3 receptors support the
development of both inotropy and spontaneous pro-
arrhythmic Ca2+ signals in ventricular myocytes stimulated
with a Gq-coupled agonist.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/119/16/3363/DC1
Key words: Inositol 1,4,5-trisphosphate, Arrhythmia, Calcium,
Ryanodine, Inotropy, Endothelin
Summary
Inositol 1,4,5-trisphosphate supports the
arrhythmogenic action of endothelin-1 on ventricular
cardiac myocytes
Andrew Proven1, H. Llewelyn Roderick1,2,*, Stuart J. Conway3, Michael J. Berridge1, Jeffrey K. Horton4,
Stephen J. Capper4 and Martin D. Bootman1
1Calcium Group, Laboratory of Molecular Signalling, Babraham Institute, Babraham, Cambridge, CB2 4AT, UK
2Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
3School of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK
4GE Healthcare, Forest Farm, Whitchurch, Cardiff, CF14 7YT, UK
*Author for correspondence (e-mail: Llewelyn.roderick@bbsrc.ac.uk)
Accepted 1 June 2006
Journal of Cell Science 119, 3363-3375 Published by The Company of Biologists 2006
doi:10.1242/jcs.03073
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
3364
receptor isotypes (denoted ETA and ETB) have been
demonstrated to cause the activation of phospholipase C
(PLC). Hydrolysis of phosphatidylinositol 4,5-bisphosphate
[PtdIns(4,5)P2] by PLC on the inner leaflet of the plasma
membrane yields two products; inositol 1,4,5-trisphosphate
[Ins(1,4,5)P3] and diacylglycerol (DAG). Ins(1,4,5)P3 is water
soluble, diffuses into cells and binds to specific receptors
(Ins(1,4,5)P3Rs) that channel Ca2+ from the lumen of the SR
(or endoplasmic reticulum) to the cytosol (Roderick and
Bootman, 2003). DAG stays in the plasma membrane, where
it can be metabolised further or activate numerous additional
effectors such as protein kinase C (PKC) and Ras (Springett et
al., 2004; Walker et al., 2003).
Several laboratories have demonstrated the expression of
Ins(1,4,5)P3R mRNA and functional protein in cardiac
myocytes from various mammalian species (Lencesova et al.,
2002; Li et al., 2005; Lipp et al., 2000; Perez et al., 1997;
Yamada et al., 2001). Also, agonist-stimulated increases in
myocyte Ins(1,4,5)P3 concentration have been monitored by
many groups in response to diverse agonists, including ET-1
(Remus et al., 2006). In addition, there are a growing number
of studies showing that increased Ins(1,4,5)P3 levels modulate
Ca2+ release from internal stores within cardiac myocytes
(Felzen et al., 1998; Gilbert et al., 1991; Mackenzie et al.,
2004a; Zima and Blatter, 2004).
The bulk of evidence for Ins(1,4,5)P3 causing Ca2+ release
in cardiac myocytes has derived from studies of atrial
myocytes, which have a higher expression of Ins(1,4,5)P3Rs
(Li et al., 2005; Lipp et al., 2000). The role of Ins(1,4,5)P3 in
ventricular myocytes is less clear. Even if Ins(1,4,5)P3Rs are
expressed and functional, it has been noted that their potential
contribution to Ca2+ signalling inside ventricular myocytes
could be modest. Within the adult mammalian heart, the ratio
of Ins(1,4,5)P3R to RyR expression is approximately 1:100
(Go et al., 1995). This would suggest that the flux of Ca2+
through Ins(1,4,5)P3Rs could be swamped by the activity of
RyRs. However, concerted opening of Ins(1,4,5)P3Rs, or
stimulation of regenerative CICR from neighbouring RyRs
could cause Ins(1,4,5)P3-mediated Ca2+ signals to have a
profound effect on cardiac Ca2+ handling.
Here, we characterised the effect of ET-1 on Ca2+ signals
within acutely-isolated ventricular myocytes. We observed two
profound effects: a positive inotropic amplification of
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depolarisation-induced Ca2+ transients and an increase in the
generation of spontaneous diastolic Ca2+ transients (SCTs).
The characteristics of the ET-1-induced SCTs were
significantly different from those evoked by digoxin and
isoproterenol in terms of their temporal occurrence and spatial
extent. Furthermore, whereas the SCTs triggered by ET-1 were
sensitive to Ins(1,4,5)P3R antagonism, those evoked by digoxin
and isoproterenol were not. These data indicate that
Ins(1,4,5)P3 can lead to the generation of pro-arrhythmic SCTs
and inotropy in ventricular myocytes.
Results
Characterisation of the positive inotropic response to ET-1
The aims of the present study were to investigate mechanisms
underlying the action of cardiotonic agents on ventricular
myocyte Ca2+ signalling. In these experiments, cells were
superfused with various agonists while being electrically paced
using field electrodes. The photometry trace shown in Fig. 1A
illustrates the typical response observed from a control
myocyte superfused with extracellular medium alone. There
was no obvious change in the pattern of field-stimulation-
evoked Ca2+ transients during the 25-minute recording. The
stability of evoked responses is also evident from the average
amplitudes of the pacing-induced Ca2+ transients, as depicted
in Fig. 1B (28 myocytes from 22 independent experiments).
An overlay of an electrically-evoked Ca2+ transient recorded in
the first 0.5 minutes of observation with another that occurred
within the same cell 25 minutes later is illustrated in Fig. 1C.
The rate of increase and decay of the Ca2+ signals, as well as
their amplitudes, were the same at both time points, suggesting
that there was no change in Ca2+ release or sequestration
dynamics over this time.
Although the responses of control ventricular cells did not
alter during recordings, the Ca2+ indicator, indo-1, which
was used to record cytoplasmic Ca2+ in the photometry
experiments, was bleached to an appreciable degree. The
bleaching of indo-1 was responsible for the progressive
increase in noise during the diastolic portions of the trace in
Fig. 1A. However, despite the decline in absolute fluorescence
emission recorded at 405 nm and 490 nm during the
experiment, the background-corrected 405:490 nm ratio was
unaffected (Fig. 1B).
Superfusion of ventricular myocytes with ET-1 (100 nM)
Fig. 1. Ca2+ transients in electrically-paced ventricular
myocytes. (A) Recordings depict the typical response of a
single ventricular myocyte immediately after isolation, loaded
with indo-1 to repetitive field stimulation. Arrows indicate field
stimulation. (B) Normalised response (mean ± s.e.m.; n=28
cells) of ventricular myocytes to electrical pacing over a 25-
minute period. (C) Traces show typical Ca2+ responses from a
single cell at the start of an experiment (black trace) and after
25 minutes of stimulation (grey trace). There were no
significant changes in the time of increase, peak amplitude or
recovery of the Ca2+ transient.
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caused a progressive increase in the amplitude of field-
stimulation-evoked Ca2+ signals (Fig. 2A,B). This positive
inotropic response became significant when the cells were
superfused with ET-1 for ~8 minutes (Fig. 2B). 64% of cells
(n=14) displayed a positive inotropic response to ET-1. The
other cells showed no significant change in their Ca2+
transients. ET-1 also appeared to modestly accelerate the
recovery of field-stimulation-evoked Ca2+ transients (see Table
1). In addition to its positive inotropic effect, ET-1 significantly
increased the incidence of SCTs. The SCTs were evident as
rapid extra Ca2+ transients that occurred shortly after field-
stimulation-evoked signals (Figs 2Aiii and iv).
To further characterise ET-1-induced inotropy, Ca2+ signals
in ventricular myocytes were observed using confocal
microscopy. The images in Fig. 2C depict the spatial properties
of pacing-evoked Ca2+ transients and an SCT. The Ca2+
transients evoked by field stimulation were always recorded as
global events with a homogenous elevation of intracellular
Ca2+, [Ca2+]i. The SCT shown in Fig. 2Ciii (at 840
milliseconds) was also evident as a homogenous Ca2+ signal.
The SCT appears as a sudden global increase of fluorescence
in the confocal images in Fig. 2Ciii (the fluorescence intensity
declined after the pacing-evoked signal, but then increased
homogenously again at 840 milliseconds). The majority of ET-
1-evoked SCTs were synchronous global Ca2+ elevations.
Characterisation of the positive inotropic response to -
adrenergic receptor stimulation
To provide a comparison with the effects of ET-1, the actions
of two additional positive inotropic agents – isoproterenol
and digoxin – were analysed. Stimulation of -adrenergic
receptors is a well-known physiological mechanism for
inducing positive inotropy in the heart (Bers, 2002). The
example photometry-traces presented in Fig. 3A and the
averaged population data in Fig. 3B illustrate the positive
inotropic response evoked by isoproterenol (100 nM). 83%
of cells (n=11) displayed a positive inotropic response to
isoproterenol. A significant inotropic effect occurred within
100 seconds, and was more rapid with isoproterenol than with
any other agonist used in this study. The positive inotropy
mediated by isoproterenol began to decline steadily after
reaching a peak at 400 seconds (Fig. 3A). Isoproterenol also
stimulated the appearance of SCTs, which became
progressively more frequent (see below). The high frequency
of SCTs is likely to be the cause of the decline of the positive
inotropy because they would have caused unloading of the
SR. This phenomenon has been noticed by others (Capogrossi
et al., 1988). Isoproterenol also accelerated the decay of Ca2+
transients (see Table 1). This is in keeping with the reported
action of PKA on phospholamban, which leads to an increase
in SERCA2a function, thereby enhancing the sequestration of
cytosolic Ca2+ (Bers, 2002).
The montage of images shown in Fig. 3C illustrate the
homogenous increase and decrease in fluorescence observed
during electrical pacing of an isoproterenol-stimulated cell.
SCTs are also evident in the confocal images following
isoproterenol stimulation for 5 minutes (Fig. 3Cii) and 12.5
minutes (Fig. 3Ciii). In the majority of cases, isoproterenol-
induced SCTs occurred during the, usually quiescent, diastolic
periods, after recovery of the field-stimulation-evoked Ca2+
signals.
Three separate SCTs were evident in the sequence of images
captured 12.5 minutes after superfusion with isoproterenol
(Fig. 3Ciii). The homogenous increases in fluorescence
observed at 630 and 1060 milliseconds indicate that these
SCTs were caused by spontaneous action potentials (see
Discussion). However, the images captured at 1690 and 1900
milliseconds reveal the initiation and propagation of a Ca2+
wave. Another SCT, which was also manifest as a Ca2+ wave,
Fig. 2. ET-1 stimulates positive inotropy and SCTs in ventricular
myocytes. (Ai-iv) Traces depict the effect of continuous superfusion
of ventricular myocytes with ET-1 (100 nM). The ET-1 superfusion
was initiated just after the trace in i was recorded. Arrows indicate
field stimulation. (B) Normalised response (mean ± s.e.m.; n=14
cells) of ventricular myocytes to electrical pacing over a 25-minute
period. *P<0.05; calculated using Student’s t-test). (C) Montages of
confocal images collected at 210-millisecond intervals obtained from
a single ventricular myocyte loaded with Fluo-4 either (i) before, (ii)
5 minutes after or 12.5 minutes (iii) after the start of superfusion with
ET-1. The cell was field-stimulated at the times indicated. Bar,
spatial scale of 15 m.
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is evident in the montage of images obtained 5 minutes after
superfusion with isoproterenol (Fig. 3Cii).
Digoxin, another well-established positive inotrope on
ventricular myocytes (Smith, 1978), also caused an increase
in the amplitude of pacing-induced Ca2+ transients (see
supplementary material Fig. S1) and triggered SCTs (see
below).
Characterisation of SCTs
In the photometry traces shown in Figs 2 and 3, SCTs are
evident as randomly-occurring Ca2+ events of varying
amplitude and time of increase. They were temporally distinct
from the pacing-evoked Ca2+ signals. Few SCTs were observed
in cells superfused with control medium alone. Only 27% of
control cells (n=28) showed SCTs that were evident in
photometry recordings, with each cell generating only a couple
of infrequent events. In the cells that did display SCTs, the
events generally occurred after the myocytes had been
continually paced for >20 minutes (Fig. 4A).
With control cells, the time of occurrence of the SCTs
relative to the field stimulation-induced Ca2+ transients
indicated two sub-populations of events (Fig. 4B). One group
of events occurred within 1 second of the previous field-
stimulation-evoked Ca2+ signal. The other sub-population of
SCTs was evident within 1-3 seconds after field stimulation.
The photometry recordings shown above were obtained by
averaging indo-1 fluorescence across intact single myocytes.
This system is appropriate for recording global Ca2+ transients
and regenerative Ca2+ waves, but non-propagating subcellular
events, such as Ca2+ sparks, would not be evident. Therefore,
to determine whether there were additional SCTs manifest
as microscopic events, real-time confocal microscopy was
employed. We have previously used this technique to monitor
Ca2+ sparks in atrial myocytes (Mackenzie et al., 2002).
Confocal microscopy indicated that spontaneous Ca2+ sparks
occurred in addition to the events that were recorded using
photometry. In some cases, Ca2+ sparks were solely transient,
spatially-restricted events, whereas other Ca2+ sparks acted as
a trigger for the initiation of regenerative Ca2+ waves. The
frequency of spontaneous Ca2+ sparks and number of active
Ca2+-spark sites was low in myocytes superfused with control
buffer alone, and it did not significantly change over a 15-
minute recording period (Fig. 4C). With non-paced myocytes,
there was also a very low frequency of SCTs observed (using
photometry; data not shown) and Ca2+ sparks (visualised with
confocal microscopy; Fig. 4D).
ET-1 evoked a substantial increase in SCT occurrence (Fig.
5A). The proportion of cells showing SCTs (70%; n=14) was
significantly higher than in control myocytes. In addition, the
frequency of SCTs in individual cells was progressively
enhanced by superfusion with ET-1 (Fig. 5A). Unlike the SCTs
observed in control cells, the events triggered by ET-1
superfusion were found to initiate within 1 second of the
previous field-stimulation-evoked Ca2+ signal (Fig. 5B). In
fact, the majority of SCTs originated on the falling phase of
field-stimulation-evoked Ca2+ signals (Fig. 2C). With cells
superfused with ET-1 for several minutes, the SCTs were often
observed as repetitive Ca2+ rises (see below). The first event
occurred within 1 second after field stimulation and was
succeeded by a variable number of SCTs that could persist for
the entire diastolic period. Confocal imaging of paced cells
indicated that there was no significant increase in the
occurrence of non-propagating Ca2+ sparks in cells superfused
with ET-1 (Fig. 5C). In non-paced ET-1-stimulated myocytes
and in control cells, the frequencies of Ca2+ sparks (Fig. 5D;
observed with confocal imaging) and SCTs (photometry data
not shown) were similar. The potent pro-arrhythmic effects of
ET-1 were therefore only evident when the cells were
electrically paced.
Although 1 M digoxin caused a similar positive inotropic
effect as 100 nM ET-1, it did not increase the incidence of
SCTs compared with control cells (Fig. 6A). By contrast, 10
M digoxin lead to a significant increase in SCT frequency
(Fig. 6B). Furthermore, all cells (n=8) eventually displayed
SCTs after being perfused with 10 M digoxin for >500
seconds (Fig. 6C). The timing of digoxin-stimulated SCTs
relative to a previous electrically-evoked Ca2+ transient is
depicted in Fig. 6D. The two clear populations of events that
were evident in control cells (Fig. 4B) were not so obvious in
cells stimulated with 10 M digoxin. Rather, the SCTs showed
a more wide-spread distribution of latencies, with a majority
occurring more than 1 second after the previous field-
stimulation-evoked Ca2+ transient.
Isoproterenol (100 nM) led to a rapid and significant
increase in the generation of SCTs (Fig. 7A) in all cells (n=12).
Similar to digoxin, the isoproterenol-evoked SCTs occurred
with a wide distribution of latencies following the previous
electrically-evoked Ca2+ transient (Fig. 7B). Unlike any of the
other agents used in this study, isoproterenol evoked a
substantial increase in the activity of non-propagating Ca2+
sparks in both paced (Fig. 7C) and unpaced (Fig. 7D)
conditions.
The average latencies for the occurrence of SCTs under
control conditions and following ET-1, digoxin and
Journal of Cell Science 119 (16)
Table 1. Temporal characteristics of pacing-evoked Ca2+ transients in control cells and in cells superfused with agonist
Time to reach amplitude peak Time of decay
t0 (milliseconds) t1440 (milliseconds) t1440:t0 ratio t0 (milliseconds) t1440 (milliseconds) t1440:t0 ratio
Control 54±2.1 68±2.9 0.79 845±17 660±18 0.78
ET-1 (100 nM) 54±2.7 64±1.5 0.84 940±22 586±46 0.62* (P<0.01)
Isoproterenol (100 nM) 61±1.8 74±4 0.82 1275±27 541±13 0.42* (P<0.01)
Digoxin (10 M) 67±3.5 76±3.1 0.88 834±13 675±20 0.81
The table shows the average (mean ± s.e.m.) increase and recovery times for field-stimulation-evoked Ca2+ transients in cells superfused with the reagents
shown. The data were sampled either before agonist addition (t0) or after 24 minutes of pacing with the appropriate reagent (t1440). The time to reach peak
amplitude was calculated as the interval between depolarisation of the cell and the maximum increase of the Ca2+ transient. The time of decay was taken as the
period between the peak Ca2+ rise and the time taken to for cytosolic Ca2+ to return to the pre-depolarisation diastolic level. The data were calculated from ten
field-stimulation-evoked Ca2+ transients from 6 myocytes for each condition (i.e. n=60 for each data point).
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isoproterenol are depicted in Fig. 8. Please note that the data
show the time between a previous field-stimulation-evoked
Ca2+ signal and the onset of the first SCT. Where SCTs
occurred as repetitive events in a diastolic period, only the
latency to the first event was measured. The plot of latencies
shows that ET-1, digoxin and isoproterenol triggered SCTs
with significantly different characteristics. The SCTs triggered
by ET-1 occurred earlier than those seen in control cells,
whereas the SCTs during superfusion with digoxin or
isoproterenol began substantially later.
In addition to their timing, another significant difference
between SCTs triggered by ET-1, digoxin or isoproterenol was
whether they were manifest as Ca2+ waves or action-potential-
evoked Ca2+ transients. The trace depicted in Fig. 9Ai shows
part of a recording from a ventricular myocyte that had been
superfused with ET-1 for 24 minutes. All field-stimulation-
evoked Ca2+ transients were succeeded by SCTs. In the
majority of cases, the SCTs had a similar amplitude and rate
of increase compared with the electrically-evoked Ca2+
transients. This is clearly illustrated in Fig. 9Aii, where a
section of the trace from Fig. 9Ai is shown on an expanded
time scale. The dashed grey lines indicate the rising phases of
an evoked Ca2+ transient and subsequent SCT. Both Ca2+
signals show a similar slope. By contrast, the SCTs observed
in digoxin- or isoproterenol-stimulated cells generally had a
lesser amplitude and a slower rate of increase. This is evident
in Fig. 9Bi and ii, which depict responses from a cell
superfused with isoproterenol for 24 minutes.
The rapidly-rising SCTs were due to spontaneous action-
potential-evoked Ca2+ transients. This is the only mechanism
by which Ca2+ events (detectable by photometry) could occur
with a rate of increase similar to field-stimulation-evoked Ca2+
signals. By contrast, the SCTs with a slower rate of increase
represented Ca2+ waves. The same designation of SCTs as Ca2+
waves or action-potential-evoked Ca2+ transients was evident
from confocal imaging of cells. The montage of images shown
in Fig. 2Diii depicts an ET-1-stimulated SCT as a rapidly
rising, spatially homogenous Ca2+ signal with an intensity
similar to the evoked Ca2+ transient. The simultaneous global
development of the SCT indicates that it was due to a
spontaneous action potential. By contrast, the isoproterenol-
stimulated SCT depicted in Fig. 3Cii was evident as a Ca2+
wave. Averaging the confocal fluorescence signal across the
whole cell (i.e. mimicking the situation with photometry)
showed that the Ca2+ wave was rising more slowly and had a
lesser amplitude than the field-stimulation-evoked Ca2+
transient (data not shown).
The SCTs recorded in photometry experiments were
classified into Ca2+ waves or action-potential-evoked Ca2+
transients on the basis of their time of increase and amplitude
(see Materials and Methods). It was evident that ET-1, digoxin
and isoproterenol all stimulated the appearance of both types
of event (Fig. 9C). However, the proportions of Ca2+ waves and
action potential-evoked Ca2+ transients were dependent on the
stimulus used. With ET-1, the majority of SCTs manifested as
action-potential-evoked Ca2+ transients, whereas digoxin and
isoproterenol largely caused Ca2+ waves (Fig. 9D). Therefore,
the SCTs triggered by ET-1 were different from those evoked
by digoxin or isoproterenol, based on analysis of their latencies
(Fig. 8) or action potential versus Ca2+ wave characteristics
(Fig. 9D).
Ins(1,4,5)P3 supports the generation of SCTs by ET-1
and stimulates positive inotropy
The typical positive inotropic effect of ET-1, and the
concomitant generation of SCTs, is illustrated in Fig. 10Ai and
Aii. Superfusion with the PLC inhibitor U73122 at 10 M
prevented the positive inotropic effect of ET-1 (Fig. 10Bi) and
also reduced the incidence of SCTs back to control levels
Fig. 3. Isoproterenol stimulates positive inotropy and SCTs in
ventricular myocytes. (Ai-iv) Traces depict the effect of continuous
superfusion of ventricular myocytes with isoproterenol (100 nM).
The isoproterenol superfusion was initiated just after the trace in i
was recorded. Arrows indicate field stimulation. (B) Normalised
response (mean ± s.e.m.; n=12 cells) of ventricular myocytes to
electrical pacing over a 25-minute period. *P<0.05; calculated using
Student’s t-test). (C) Montages of confocal images obtained from a
single ventricular myocyte loaded with Fluo-4 either (i) before, (ii) 5
minutes after or 12.5 minutes (iii) after the start of superfusion with
isoproterenol. The cell was field stimulated at the times indicated by
the white arrows. N.B. In panel Cii, the initial image of the cell (i.e.
at 0 milliseconds) shows elevated Ca2+ at the extreme ends of the
cell. This reflects the final stage of a Ca2+ wave that had propagated
horizontally throughout the myocyte. Bar, spatial scale of 15 m.
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evoked Ca2+ signal. (C,D) Number of spontaneous Ca2+ sparks recorded using confocal imaging of electrically (C) paced or (D) unpaced cells.
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(compare Fig. 4A with Fig. 10Bii). When applied on its own
to electrically paced cells, U73122 caused a unsignificant
reduction of the field-stimulation-evoked Ca2+ signals and a
slight decrease in the number of SCTs (Fig. 10Ci and Cii).
To examine the role of Ins(1,4,5)P3 in ET-1 responses, the
membrane-permeant Ins(1,4,5)P3R antagonist 2-APB was
used. The traces in Fig. 11A illustrate the typical
development of inotropy and SCTs during prolonged
incubation with ET-1. Following 24 minutes of superfusion
with ET-1 (100 nM), the peak into-1 signal (measured as a
ratio of 405 nm to 490 nm emission) had increased by 34%.
In addition, the progressive increase in the incidence of SCTs
is apparent, with trains of multiple SCTs being manifest in
the later stages of the recording. Concurrent superfusion of
ventricular myocytes with ET-1 (100 nM) and 2-APB (2 M)
significantly reduced the incidence of SCTs (Fig. 11B,C).
Although it is well-known that 2-APB can affect a number
of cellular processes (Bootman et al., 2002; Peppiatt et al.,
2003) at the concentration used in this study and previously
(Mackenzie et al., 2002), it does not appear to have non-
specific actions. In control experiments, cells that had been
superfused continuously with 2 M 2-APB displayed field-
stimulation-evoked Ca2+ signals with unaltered peak
amplitudes or kinetics (supplementary material Fig. S2).
Furthermore, the SCTs triggered by isoproterenol or digoxin
were not significantly inhibited by 2-APB (supplementary
material Fig. S3), suggesting that the events triggered by these
agonists have a different underlying mechanism and that
2-APB does not generally block spontaneous Ca2+ release.
2-APB did not affect the rate or extent of inotropic response in
isoproterenol- or digoxin-stimulated cells (data not shown).
The most direct method for stimulating Ins(1,4,5)P3Rs in
situ while avoiding the pleiotropic actions of hormones is to
Journal of Cell Science 119 (16)
*
*
*
Fig. 8. Bar graph, showing the average latency for the initiation of
SCTs during superfusion with control medium or the agonists shown.
* indicates data significantly different from control (determined
using Kruskal-Wallis one-way ANOVA with Bonferroni correction).
The data represent mean ± s.e.m. (n=60 SCTs for each condition).
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use the membrane-permeant Ins(1,4,5)P3
ester first introduced by Tsien and colleagues
(Li et al., 1997). We (Chen et al., 2004; Kasri
et al., 2004; Mackenzie et al., 2002; Peppiatt
et al., 2003) and several other groups
(Johenning et al., 2002; Tovey et al., 2003;
Vermassen et al., 2003) have used the
Ins(1,4,5)P3 ester to specifically activate
Ins(1,4,5)P3R-mediated Ca2+ release. All
reported effects of Ins(1,4,5)P3 ester are
consistent with a sole action of the
compound on Ins(1,4,5)P3Rs.
Incubation of ventricular myocytes with
Ins(1,4,5)P3 ester (10 M) led to a
progressive increase in SCTs, although at a
lower frequency than observed with 100 nM
ET-1 (Fig. 11D). When 2-APB was applied
simultaneously with Ins(1,4,5)P3 ester, the
SCTs were significantly reduced (Fig.
11E,F). Application of Ins(1,4,5)P3 ester
also stimulated an increase in the amplitude
of pacing-evoked Ca2+ transients. This
positive inotropic effect was abolished by 2-
APB (supplementary material Fig. S4).
These data show that direct activation of
Ins(1,4,5)P3Rs with the Ins(1,4,5)P3 ester
mimics the effects of ET-1 on ventricular
myocytes.
As described above, ET-1 increased the
proportion of cells that displayed SCTs. A
similar effect was observed with Ins(1,4,5)P3
ester (Fig. 12A). For myocytes treated with
ET-1 or Ins(1,4,5)P3 ester, 2-APB reduced
the percentage of cells showing SCTs back
to control levels (Fig. 12A). The SCTs
observed during Ins(1,4,5)P3 ester
superfusion were similar in their
characteristics to those evoked by ET-1. In
particular, they tended to occur during the
recovery-phase of a field-stimulation-evoked
Ca2+ transient. This is evident from the traces
depicted in Fig. 11D. The average latency for
SCT occurrence during Ins(1,4,5)P3 ester
superfusion was comparable with that for ET-1 (Fig. 12B).
Concurrent application of 2-APB (2 M) with ET-1 or
Ins(1,4,5)P3 ester increased the latency for SCT generation to
control levels (Fig. 12B). These data are consistent with the
notion that Ins(1,4,5)P3Rs are largely responsible for the SCTs
that occur during the recovery of field-stimulation-evoked Ca2+
transients. Inhibition of Ins(1,4,5)P3Rs by 2-APB prevents
these early SCTs, leaving only the events that would ordinarily
be present during control stimulation.
Discussion
Here, we investigated the contribution of Ins(1,4,5)P3 to the
well-characterised physiological and pathological actions of
ET-1. It is established that ET-1 acts as a positive inotropic
agent in the heart (Russell and Molenaar, 2000). However, in
addition to stimulating the contraction of the heart, ET-1 can
evoke arrhythmias (Duru et al., 2001). ET-1 binds to receptors
on the surface of cardiac myocytes and stimulates the activity
of PLC to produce the intracellular messengers DAG and
Ins(1,4,5)P3. Activation of PKC by DAG has been widely
implicated in the positive inotropic effect of ET-1 (He et al.,
2000; Pi et al., 2003), but the role played by Ins(1,4,5)P3 has
not been thoroughly examined in ventricular myocytes.
To determine the unique characteristics of SCTs evoked by
ET-1, we used two additional stimuli – isoproterenol and
digoxin – that also have established positive inotropic and
arrhythmic actions (Baartscheer et al., 2003; Smith, 1978;
Tsien et al., 1978). The mechanism underlying isoproterenol-
and digoxin-induced SCTs is believed to principally involve
enhanced SR Ca2+ loading (Capogrossi et al., 1988). It has
been demonstrated that an increase in the Ca2+ content of the
SR promotes the occurrence of spontaneous Ca2+ waves
(Kurebayashi et al., 2004; Lukyanenko et al., 1999), and that
this hemorrhaging of Ca2+ limits the inotropic effect of
neurohormonal agents (Capogrossi et al., 1988). Consistent
with these concepts, we found that the SCTs in response to
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both isoproterenol and digoxin were most commonly observed
to be Ca2+ waves (Fig. 3C and Fig. 8). Furthermore, the
inotropy stimulated by isoproterenol gradually declined upon
reaching the peak amplitude (Fig. 3). The decrease in the
inotropic effect was temporally correlated with the increase in
SCT frequency (Fig. 7).
It is evident from a number of criteria that the SCTs evoked
by ET-1 were distinct from those triggered by isoproterenol or
digoxin. Whereas 2-APB dramatically reduced the occurrence
of SCTs during ET-1 stimulation (Fig. 11), the Ins(1,4,5)P3R
antagonist did not have a significant effect on the spontaneous
events observed with isoproterenol or digoxin (supplementary
material Fig. S3). In addition, the SCTs triggered by ET-1
occurred largely on the decreasing phase of a previous field-
stimulation-evoked Ca2+ signal (Fig. 9A). By contrast,
isoproterenol and digoxin promoted events that were more
likely to occur when Ca2+ had recovered to diastolic levels
(Figs 6 and 7). Furthermore, the majority of spontaneous events
recorded during application of ET-1 had rates of increase and
amplitudes consistent with them being action potentials (Fig.
9), rather than Ca2+ waves. The clear differences between SCTs
induced by ET-1, isoproterenol and digoxin, point to distinct
mechanisms for their generation. The sensitivity of ET-1-
evoked SCTs to the PLC anatagonist U73122 (Fig. 10) and the
Ins(1,4,5)P3R antagonist 2-APB (Fig. 11), and the similarity of
the spontaneous events triggered by application of Ins(1,4,5)P3
ester (Figs 11 and 12), support the notion that Ins(1,4,5)P3Rs
are responsible. It has been noticed previously that the focal
origin of ET-1-mediated arrhythmias within the heart favours
a mechanism of triggered activity, such as that observed by
stimulating Ins(1,4,5)P3Rs (Duru et al., 2001).
Within atrial myocytes, which have a higher expression of
Ins(1,4,5)P3Rs than ventricular cells (Lipp et al., 2000),
elevation of Ins(1,4,5)P3 gives rise to a substantial positive
inotropic effect (Mackenzie et al., 2004a; Zima and Blatter,
2004). In the present study using ventricular myocytes, we
similarly observed that direct stimulation of Ins(1,4,5)P3Rs
using the Ins(1,4,5)P3 ester caused an increase in the amplitude
of field-stimulation-evoked Ca2+ transients (Fig. 11D and
supplementary material Fig. S4). The positive inotropic effect
of the Ins(1,4,5)P3 ester, albeit significant, was not as
substantial as that observed with ET-1. This may be due to ET-
1 causing a more profound increase in the cellular Ins(1,4,5)P3
concentration, perhaps in a critical subcellular location such as
T-tubule membranes (Robu et al., 2003), which we cannot
precisely match using passive diffusion of the Ins(1,4,5)P3
Journal of Cell Science 119 (16)
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ester. It is also plausible that ET-1 utilises other mechanisms,
in addition to Ins(1,4,5)P3, that work synergistically to promote
positive inotropy in ventricular myocytes. The most obvious
candidate is PKC (Pi et al., 2003). However, we have not
observed effects of either PKC agonists (10 M phorbol 12,13
dibutyrate) or antagonists (10 M chelerythrine or 10 M
calphostin C) that would be consistent with PKC mediating the
actions of ET-1 on EC-coupling (M.D.B., A.P. and H.L.R.,
unpublished data).
The most striking differences between the SCTs mediated
by ET-1, and those triggered by isoproterenol and digoxin were
their timing and manifestation as Ca2+ waves or action
potentials. As described above, ET-1-evoked SCTs occurred
during the recovery of a previous field-stimulation-evoked Ca2+
signal. The reason for this proximity of the events may be
explained by the co-dependence of Ins(1,4,5)P3Rs on
Ins(1,4,5)P3 and Ca2+. Although Ins(1,4,5)P3 is necessary for
Ins(1,4,5)P3R opening, the activation of these channels is
complex, and their open probability depends on the ambient
Ca2+ concentration (Bezprozvanny et al., 1991). Up to
approximately 500 nM, Ca2+ works synergistically with
Ins(1,4,5)P3 to activate Ins(1,4,5)P3Rs, whereas higher
concentrations of Ca2+ inhibit channel activation (Missiaen et
al., 1992). Type 2 Ins(1,4,5)P3Rs, the predominant cardiac
isoform, have been shown to possess this ‘bell-shaped’
dependence on Ca2+ concentration (Miyakawa et al., 1999).
It is therefore plausible that Ins(1,4,5)P3Rs are inhibited by
the Ca2+ signals that occur during L-type VOC opening but, as
the cytosolic Ca2+ concentration slowly recovers, it reaches a
threshold where Ins(1,4,5)P3Rs become active, thereby
triggering an SCT. In addition, the opening of some
Ins(1,4,5)P3Rs during Ca2+ flux through L-type VOC could
explain the positive inotropic effects of Ins(1,4,5)P3
(Mackenzie et al., 2004b). Owing to their dual requirement for
Ins(1,4,5)P3 and Ca2+, Ins(1,4,5)P3Rs would be ‘tuned’ to the
electrical activity of the cell through the activity of L-type
VOCs. By contrast, with digoxin and isoproterenol the SCTs
are caused by SR Ca2+ overload. The consequent sensitisation
of RyRs by the enhanced Ca2+ load would make them prone
to spontaneous opening without the need for a triggering
signal. The RyRs could therefore open randomly after a field-
stimulation-evoked Ca2+ signal.
It is unclear why ET-1 produced a higher proportion of SCTs
that manifested themselves as action potentials, whereas
isoproterenol and digoxin largely triggered Ca2+ waves (Fig.
9). All spontaneous Ca2+-release events that reach the plasma
membrane cause cellular depolarisation. This is due to the
activation of depolarising currents, for example arising from
forward-mode Na+-Ca2+ exchange and Ca2+-activated Cl–
efflux (Boyden and ter Keurs, 2001). The magnitude of cellular
depolarisation depends on the proportion of the membrane that
interacts with the spontaneous Ca2+ signal (Capogrossi et al.,
1987; Mackenzie et al., 2002). The Ca2+ waves that were
largely evident in cells stimulated with isoproterenol or digoxin
would be expected to cause a modest depolarisation that is sub-
threshold for triggering an action potential, because such Ca2+
waves have a limited spatial extent at any moment. For ET-1
to promote SCTs most commonly as action potentials, the
trigger Ca2+ signal arising from Ins(1,4,5)P3Rs must be
widespread and must occur in close proximity to the
sarcolemma. The exact location of Ins(1,4,5)P3Rs in adult
ventricular myocytes is presently not clear. It has been
suggested that they are present at the nuclear envelope (Bare
et al., 2005) and diadic junctions (Mohler et al., 2003).
However, further studies are required to firmly establish the
locations of Ins(1,4,5)P3Rs in ventricular cells, and to
determine whether different populations of these channels have
specific functions.
In conclusion, our data indicate that Ins(1,4,5)P3Rs are
expressed and functional in adult ventricular myocytes.
Activation of Ins(1,4,5)P3Rs within electrically paced
myocytes leads to the generation of spontaneous Ca2+-release
transients and enhanced EC-coupling. It is important to notice
that during various cardiac pathologies, such as heart failure
or mitral valve disease, the expression of Ins(1,4,5)P3Rs is
increased (Go et al., 1995; Yamada et al., 2001). In principle,
this would make the heart even more susceptible to the pro-
arrhythmogenic action of Ins(1,4,5)P3. It is therefore plausible
that Ins(1,4,5)P3Rs are a putative target for therapeutic
intervention in some forms of arrhythmia.
Materials and Methods
Materials
Collagenase type II was purchased from Worthington Biochemical Corporation
(Lorne Laboratories Ltd, UK). Endothelin-1 (ET-1) was obtained from Calbiochem.
Salts for extracellular solutions were purchased form Sigma-Aldrich or BDH. Ca2+-
sensitive fluorescent indicators were purchased from Molecular Probes (Cambridge
Bioscience, UK). The PLC inhibitor U73122 was from Calbiochem, UK and the
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Fig. 12. Inhibition of Ins(1,4,5)P3-evoked SCTs by 2-APB. (A)
Proportion of cells that displayed one or more SCTs during a 25-
minute photometry experiment while being superfused with the
reagents shown. (B) Average latency until the first SCT for cells
stimulated with the reagents shown. *P<0.05 (significantly different
from control); calculated using Student’s t-test).
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membrane-permeant Ins(1,4,5)P3R antagonist 2-aminoethoxydiphenyl borate (2-
APB) was from Sigma, UK. Rats were obtained from Harlan (Bicester, UK).
Myocyte isolation
Wistar rats weighing approximately 250 g were anaesthetised in a CO2 chamber and
then killed by cervical dislocation. The heart was then dissected from the thorax
and positioned on a modified Langendorff apparatus and perfused in a retrograde
manner with HEPES buffer (NaCl 135 mM, KCl 5 mM, CaCl2 1 mM HEPES 10
mM, glucose 10 mM and MgCl2 0.4 mM, pH 7.35) at 37°C. This was followed by
superfusion with a low-Ca2+ buffer (NaCl 120 mM, KCl 5 mM, CaCl2 80 M,
HEPES 10 mM, taurine 20 mM, glucose 20 mM, MgSO4 5 mM, NTA 5.5 mM, and
pyruvate 5 mM, pH 6.96) for 3.5 minutes. Following the low-Ca2+ buffer, an enzyme
buffer (NaCl 120 mM, KCl 5 mM, CaCl2 35 M, HEPES 10 mM, taurine 20 mM,
glucose 20 mM, MgSO4 5 mM and pyruvate 5 mM, pH 7.4) was recirculated
through the apparatus for 10 minutes. This solution also contained 118 international
units ml–1 type II collagenase (Worthington, UK). Following dissociation of the
myocytes they were allowed to settle, and Ca2+ was reintroduced in an incremental
manner to prevent intracellular Ca2+ overload and hypercontracture. The myocytes
were kept at room temperature until ready for use. Only rod-shaped myocytes
without any signs of deterioration and without spontaneous activity at rest were used
for experiments. The myocytes were settled on poly-L-lysine-coated coverslips for
45 minutes before loading them with a fluorescent Ca2+ indicator. All experiments
were performed in accordance with the guidelines from the code of practice for
humane killing under Schedule 1 of the Animals (Scientific Procedures) Act 1986.
Photometry and confocal imaging, and field stimulation
For photometry experiments, cells were loaded with indo-1 by incubation with indo-
1/AM (3 M for 30 minutes). The cells were then washed in HEPES buffer and
left for 30 minutes to allow complete de-esterification. For laser-scanning confocal
microscopy (LSCM) experiments, cells were loaded with Fluo-4 by using a similar
procedure to that for indo-1, except that the myocytes were incubated with 2 M
Fluo-4/AM for 20 minutes.
For the photometry recordings, coverslips bearing indo-1-loaded myocytes were
placed on the stage of an inverted microscope (Nikon Diaphot) and superfused with
HEPES buffer containing 1 mM CaCl2. The cells were stimulated for 2 milliseconds
at 40 V with a pair of platinum field electrodes placed at equal distance from the
cell (distance between electrodes was 1 cm). The pacing frequency was 0.33 Hz.
Indo-1 was excited at a wavelength of 360 nm; the fluorescence emission at 405
nm and 490 nm was sampled using two independent photomultiplier detectors every
10 milliseconds. The photomultiplier signals were digitised using an analogue to
digital converter controlled by PhoCal Pro (PerkinElmer, UK). The background
fluorescence at 405 nm and 490 nm emission was determined from fields of view
without cells, and this was automatically subtracted from the subsequent
experimental records by the software. The cells were paced continually throughout
an experiment. However, to reduce bleaching of the indicator, indo-1 fluorescence
was sampled discontinuously (30-second illumination and recording period
followed by 90 seconds without illumination). The fluorescence ratio was converted
into Ca2+ concentration using a calibration procedure described previously
(Callewaert et al., 1991).
For the confocal recordings, coverslips bearing Fluo-4-loaded myocytes were
placed on the stage of an inverted microscope (Nikon TE 300) and superfused with
HEPES buffer containing 1 mM CaCl2. The pacing apparatus and conditions were
the same as those described above for photometry. The LSCM images were captured
using a NORAN Oz (Middleton, USA) and data were acquired using Noran’s
Intervision software running on a Silicon Graphics computer. 2D confocal images
(512115 pixels; confocal slit aperture 25 m) were acquired at 120 Hz. Laser
excitation of Fluo-4 was applied in 10-second bursts at pre-set times over a 12.5-
minute period.
Superfusion of cells was accomplished using a gravity-driven flow of solution
over the top of the cells. Solution exchange around a cell took less than 1 second.
All experiments were performed at room temperature (20-22°C), because cell
viability and dye loading is prolonged at this temperature. Before the experiments,
all cells were paced for a brief period to establish a steady-state Ca2+ response.
During this period, there was a ‘positive staircase’ indicative of Ca2+ loading.
Generally, it took between 10 and 20 depolarisations to reach equilibrium.
Designation of SCTs as action potentials or Ca2+ waves
The SCTs recorded in this study were manifest as three different types of event –
Ca2+ sparks, Ca2+ waves and action-potential-evoked Ca2+ transients. Ca2+ sparks
were only evident in confocal recordings, because their amplitude was too low to
make a significant change to the whole-cell fluorescence that was monitored in
photometry experiments. However, within confocal recordings Ca2+ sparks were
very obvious as rapid (time to reach amplitude peak <100 milliseconds) spatially
restricted (diameter <4 m) events.
The designation of SCTs as Ca2+ waves or action potential-evoked Ca2+ transients
was obvious from photometry and confocal recordings. SCTs that were manifest as
action-potential-evoked Ca2+ transients had the same amplitude and rates of increase
(>2000 nM s–1) as Ca2+ signals triggered by field stimulation. By contrast, Ca2+
waves had variable amplitudes, which were always less than the field-stimulation-
evoked Ca2+ transients, and they arose more slowly (1000 nM s–1).
These criteria for designating SCTs as action-potential-evoked Ca2+ transients or
Ca2+ waves are consistent with findings in a previous study (Mackenzie et al., 2003),
where we used simultaneous imaging and electrophysiology to verify that the spatial
pattern of the SCTs correlated with the magnitude of delayed-after-depolarisations
(DADs). Only SCTs that had the same spatial and temporal properties because field-
stimulation-evoked Ca2+ transients were found to correlate with substantial
membrane depolaristion (Mackenzie et al., 2003). By contrast, Ca2+ waves produced
sub-threshold DADs and the cells did not fully depolarise.
Occasionally, Ca2+ recordings showed complex signals that resulted from Ca2+
waves causing action potentials. In these cases, the slowly rising Ca2+ signal due a
Ca2+ wave was observed to abruptly accelerate when the action potential was
triggered. Such ‘mixed’ events were not included in the analysis described here.
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